These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19949103)

  • 21. A structurally dynamic N-terminal helix is a key functional determinant in staphylococcal complement inhibitor (SCIN) proteins.
    Garcia BL; Summers BJ; Ramyar KX; Tzekou A; Lin Z; Ricklin D; Lambris JD; Laity JH; Geisbrecht BV
    J Biol Chem; 2013 Jan; 288(4):2870-81. PubMed ID: 23233676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5.
    Strunk RC; Giclas PC
    J Immunol; 1980 Feb; 124(2):520-6. PubMed ID: 7356706
    [No Abstract]   [Full Text] [Related]  

  • 23. Staphylococcal complement inhibitor: structure and active sites.
    Rooijakkers SH; Milder FJ; Bardoel BW; Ruyken M; van Strijp JA; Gros P
    J Immunol; 2007 Sep; 179(5):2989-98. PubMed ID: 17709514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition of Staphylococcus aureus by human phagocytes. Signals and disguises of the bacterial surface.
    Peterson PK; Quie PG; Kim Y; Wilkinson BJ; Verbrugh HA; Verhoef J
    Scand J Infect Dis Suppl; 1983; 41():67-78. PubMed ID: 6589763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure/function of C5 convertases of complement.
    Rawal N; Pangburn MK
    Int Immunopharmacol; 2001 Mar; 1(3):415-22. PubMed ID: 11367526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of peptidic inhibitors of the alternative complement pathway based on Staphylococcus aureus SCIN proteins.
    Summers BJ; Garcia BL; Woehl JL; Ramyar KX; Yao X; Geisbrecht BV
    Mol Immunol; 2015 Oct; 67(2 Pt B):193-205. PubMed ID: 26052070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage complement receptors and pathogen clearance.
    van Lookeren Campagne M; Wiesmann C; Brown EJ
    Cell Microbiol; 2007 Sep; 9(9):2095-102. PubMed ID: 17590164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
    Ito S; Tamura N; Fujita T
    Immunology; 1989 Dec; 68(4):449-52. PubMed ID: 2481642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway.
    Carlsson F; Sandin C; Lindahl G
    Mol Microbiol; 2005 Apr; 56(1):28-39. PubMed ID: 15773976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional Characterization of Alternative and Classical Pathway C3/C5 Convertase Activity and Inhibition Using Purified Models.
    Zwarthoff SA; Berends ETM; Mol S; Ruyken M; Aerts PC; Józsi M; de Haas CJC; Rooijakkers SHM; Gorham RD
    Front Immunol; 2018; 9():1691. PubMed ID: 30083158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement fixation in acute serum sickness: assembly of glomerular-bound C3-convertase.
    Bartolotti SR; Peters DK
    Clin Exp Immunol; 1979 Sep; 37(3):391-8. PubMed ID: 389495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F; Kijlstra A
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial complement evasion.
    Rooijakkers SH; van Strijp JA
    Mol Immunol; 2007 Jan; 44(1-3):23-32. PubMed ID: 16875737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.
    Wong WW; Farrell SA
    J Immunol; 1991 Jan; 146(2):656-62. PubMed ID: 1670949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement activation by heat-killed human kidney cells: formation, activity, and stabilization of cell-bound C3 convertases.
    Baker PJ; Adler S; Yang Y; Couser WG
    J Immunol; 1984 Aug; 133(2):877-81. PubMed ID: 6376629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colonization and infection of the human host by staphylococci: adhesion, survival and immune evasion.
    Foster TJ
    Vet Dermatol; 2009 Oct; 20(5-6):456-70. PubMed ID: 20178484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition.
    Santi P; Joiner KA; Hammer CH; Frank MM; Tosi R
    J Immunol; 1987 May; 138(10):3385-91. PubMed ID: 2952716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement regulator C4BP binds to Staphylococcus aureus and decreases opsonization.
    Hair PS; Wagner SM; Friederich PT; Drake RR; Nyalwidhe JO; Cunnion KM
    Mol Immunol; 2012 Apr; 50(4):253-61. PubMed ID: 22333221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A structural basis for complement inhibition by Staphylococcus aureus.
    Hammel M; Sfyroera G; Ricklin D; Magotti P; Lambris JD; Geisbrecht BV
    Nat Immunol; 2007 Apr; 8(4):430-7. PubMed ID: 17351618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.